# Danish C25 stock index performance

> Developing situation record from CLSTR: https://clstr.news/situations/danish-c25-stock-index-performance
> Updated: 2026-11-09T07:14:59.000Z. Sources: 2. Developments: 2.

The Danish C25 index has shown upward movement through late 2026. On October 28, the index remained stable at 1,916.01, representing a 5.04 percent increase since the start of the year. During this period, Genmab shares surged 29.06 percent, contributing to high turnover, while GN Store Nord and Novo Nordisk experienced declines.

By November 9, the index rose to 2,025.43, a 0.82 percent daily increase that brought the year-to-date growth to 11.04 percent. Gains were led by ISS A/S and Genmab. Genmab reported third-quarter revenue growth of 16 percent to 1.187 billion USD and an operating profit of 431 million USD, which exceeded forecasts. Despite these results, the stock showed volatility following its strong yearly performance.

## Timeline

### 2026-11-09: Danish C25 index rises as ISS and Genmab lead gains

The Danish C25 index rose 0.82 percent on Monday, driven by gains in ISS A/S and Genmab, despite mixed results for other major stocks.

2 sources. https://clstr.news/cluster/danish-c25-index-rises-as-iss-and-genmab-lead-gains

### 2026-10-28: C25 Index remains stable as Genmab shares surge

The C25 index closed stable at 1,916.01 on October 28, led by a 29.06 percent surge in Genmab shares.

2 sources. https://clstr.news/cluster/c25-index-remains-stable-as-genmab-shares-surge

---
Cite as: Danish C25 stock index performance. CLSTR, https://clstr.news/situations/danish-c25-stock-index-performance
